American Action Forum Issues Commentary: Poor Incentives in the Prescription Drug Market - An Anticoagulant Case Study
April 19, 2024
April 19, 2024
WASHINGTON, April 19 (TNSres) -- The American Action Forum issued the following commentary:
* * *
Poor Incentives in the Prescription Drug Market: An Anticoagulant Case Study
By Laura Hobbs
Executive Summary
* Both the United States and the United Kingdom (UK) have established price-control regulations that apply to the most widely used medications - specifically, those medications with the overall highest spending, rather than tho . . .
* * *
Poor Incentives in the Prescription Drug Market: An Anticoagulant Case Study
By Laura Hobbs
Executive Summary
* Both the United States and the United Kingdom (UK) have established price-control regulations that apply to the most widely used medications - specifically, those medications with the overall highest spending, rather than tho . . .